{"id":238166,"title":"Diamorphine being added to list of opioids (Part B): Notice of amendment - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T05:38:48.352000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/submission-targeted-rm-plans-commitments-prescription-opioid-containing-products-guidance-industry/diamorphine-added-list-opioids-part-b.html?wbdisable=true","snippet":"Diamorphine being added to list of opioids (Part B): Notice of amendment - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the workplace Immigration and…","rawSnapshotUrl":"/api/snapshots/raw/238166","browseUrl":"https://replay.healtharchive.ca/job-1/20250419053848/https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/submission-targeted-rm-plans-commitments-prescription-opioid-containing-products-guidance-industry/diamorphine-added-list-opioids-part-b.html?wbdisable=true#ha_snapshot=238166","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}